Mustang Bio Statistics

Total Valuation

Mustang Bio has a market cap or net worth of $8.01 million. The enterprise value is $5.47 million.

Market Cap	8.01M
Enterprise Value	5.47M

Important Dates

The last earnings date was Friday, November 8, 2024, after market close.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Mustang Bio has 47.72 million shares outstanding. The number of shares has increased by 151.91% in one year.

Current Share Class	46.87M
Shares Outstanding	47.72M
Shares Change (YoY)	+151.91%
Shares Change (QoQ)	+59.32%
Owned by Insiders (%)	0.38%
Owned by Institutions (%)	3.71%
Float	41.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21,435.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-96.52%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$292,700
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.38% in the last 52 weeks. The beta is 1.77, so Mustang Bio's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	-87.38%
50-Day Moving Average	0.23
200-Day Moving Average	0.37
Relative Strength Index (RSI)	33.19
Average Volume (20 Days)	669,717

Short Selling Information

The latest short interest is 253,361, so 0.53% of the outstanding shares have been sold short.

Short Interest	253,361
Short Previous Month	424,910
Short % of Shares Out	0.53%
Short % of Float	0.62%
Short Ratio (days to cover)	0.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.44M
Pretax Income	-40.10M
Net Income	-23.42M
EBITDA	-20.53M
EBIT	-21.44M
Earnings Per Share (EPS)	-$1.15

Full Income Statement

Balance Sheet

The company has $3.53 million in cash and $983,000 in debt, giving a net cash position of $2.54 million or $0.05 per share.

Cash & Cash Equivalents	3.53M
Total Debt	983,000
Net Cash	2.54M
Net Cash Per Share	$0.05
Equity (Book Value)	-8.66M
Book Value Per Share	-0.23
Working Capital	-8.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.67 million and capital expenditures -$30,000, giving a free cash flow of -$16.70 million.

Operating Cash Flow	-16.67M
Capital Expenditures	-30,000
Free Cash Flow	-16.70M
FCF Per Share	-$0.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mustang Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-151.91%
Shareholder Yield	-151.91%
Earnings Yield	-292.43%
FCF Yield	-208.52%

Analyst Forecast

The average price target for Mustang Bio is $2.00, which is 1,091.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.00
Price Target Difference	1,091.90%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 4, 2023. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Apr 4, 2023
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1